CAR--话题@MedSci

#CAR-#

459篇内容 | 2266人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781188, encodeId=2ff81e81188ab, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=全球CAR-T临床研究项目盘点：4年新增项目数量翻4.5倍, objectType=article, longId=114400, objectId=b3b0114400a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3b0114400a0, replyNumber=0, likeNumber=67, createdTime=2018-02-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3b0114400a0, moduleTitle=全球CAR-T临床研究项目盘点：4年新增项目数量翻4.5倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3b0114400a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781174, encodeId=5ef51e8117407, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=科济生物启动全球CLDN18.2-CAR-T临床试验, objectType=article, longId=108984, objectId=fa0f108984ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa0f108984ee, replyNumber=0, likeNumber=84, createdTime=2017-09-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa0f108984ee, moduleTitle=科济生物启动全球CLDN18.2-CAR-T临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa0f108984ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781239, encodeId=f29b1e81239d3, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature：重磅！单个CAR-T细胞让癌症患者5年内保持无癌状态, objectType=article, longId=140164, objectId=275c14016410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=275c14016410, replyNumber=0, likeNumber=41, createdTime=2018-09-22, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=275c14016410, moduleTitle=Nature：重磅！单个CAR-T细胞让癌症患者5年内保持无癌状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=275c14016410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781194, encodeId=569f1e81194fc, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=全球首条全自动、全封闭的CAR-T细胞CMC生产线首次亮相国内, objectType=article, longId=121051, objectId=9f6312105179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f6312105179, replyNumber=0, likeNumber=65, createdTime=2017-12-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f6312105179, moduleTitle=全球首条全自动、全封闭的CAR-T细胞CMC生产线首次亮相国内, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f6312105179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781199, encodeId=f21f1e81199f1, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=JAMA：CAR-T治疗：希望与挑战共存, objectType=article, longId=121964, objectId=b6551219643d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6551219643d, replyNumber=0, likeNumber=80, createdTime=2018-05-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6551219643d, moduleTitle=JAMA：CAR-T治疗：希望与挑战共存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6551219643d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781220, encodeId=f2a41e812200a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood:CD19 CAR-T疗法引发脓毒症随意使用如同与虎谋皮？, objectType=article, longId=131530, objectId=aaec1315301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaec1315301a, replyNumber=0, likeNumber=69, createdTime=2019-01-21, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaec1315301a, moduleTitle=Blood:CD19 CAR-T疗法引发脓毒症随意使用如同与虎谋皮？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaec1315301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781187, encodeId=579c1e81187ec, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=近50万美元的定价贵不贵？ CAR-T疗法或建立新“支付体系”, objectType=article, longId=114254, objectId=c31611425448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c31611425448, replyNumber=0, likeNumber=66, createdTime=2017-10-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c31611425448, moduleTitle=近50万美元的定价贵不贵？ CAR-T疗法或建立新“支付体系”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c31611425448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781178, encodeId=bcbe1e811782a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Leukemia：中科院广州生物院在CAR-T细胞免疫治疗研究上取得新进展, objectType=article, longId=111608, objectId=f515111608ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f515111608ef, replyNumber=0, likeNumber=68, createdTime=2018-06-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f515111608ef, moduleTitle=Leukemia：中科院广州生物院在CAR-T细胞免疫治疗研究上取得新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f515111608ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781210, encodeId=76fd1e81210c5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=欧盟，美国在加速审查诺华的CAR-T疗法Kymriah, objectType=article, longId=126809, objectId=17ef12680968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ef12680968, replyNumber=0, likeNumber=84, createdTime=2018-09-14, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ef12680968, moduleTitle=欧盟，美国在加速审查诺华的CAR-T疗法Kymriah, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ef12680968)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781203, encodeId=0bf71e812033a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CLIN CANCER RES：靶向ICAM-1的CAR-T疗法治疗晚期甲状腺癌, objectType=article, longId=124466, objectId=e0e51244667a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0e51244667a, replyNumber=0, likeNumber=71, createdTime=2018-10-25, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0e51244667a, moduleTitle=CLIN CANCER RES：靶向ICAM-1的CAR-T疗法治疗晚期甲状腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0e51244667a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781171, encodeId=09f41e811711b, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle= SCI TRANSL MED :大牛Carl June参与发表论文：CAR-T治疗实体瘤“人体试验”结果公布，有两大障碍需克服, objectType=article, longId=106826, objectId=4ca810682632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ca810682632, replyNumber=0, likeNumber=76, createdTime=2018-03-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ca810682632, moduleTitle= SCI TRANSL MED :大牛Carl June参与发表论文：CAR-T治疗实体瘤“人体试验”结果公布，有两大障碍需克服, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ca810682632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781177, encodeId=793e1e81177fd, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, objectType=article, longId=111488, objectId=f6591114889d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6591114889d, replyNumber=0, likeNumber=67, createdTime=2018-03-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6591114889d, moduleTitle=美国食药监局正式批准诺华公司CAR-T疗法，系全球首例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6591114889d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781207, encodeId=e0411e8120749, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=糜坚青教授：CAR-T治疗新近进展及安全性管理策略, objectType=article, longId=126130, objectId=68b6126130fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68b6126130fd, replyNumber=0, likeNumber=69, createdTime=2018-08-24, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68b6126130fd, moduleTitle=糜坚青教授：CAR-T治疗新近进展及安全性管理策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68b6126130fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781164, encodeId=7c7e1e81164da, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=继CAR-T之后，TCR技术或成为第3代免疫疗法明星, objectType=article, longId=105401, objectId=481810540199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481810540199, replyNumber=0, likeNumber=86, createdTime=2017-10-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481810540199, moduleTitle=继CAR-T之后，TCR技术或成为第3代免疫疗法明星, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=481810540199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781184, encodeId=e02f1e8118405, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=美叫停CAR-T 韩启德院士带来新技术狂热下的冷思考, objectType=article, longId=112550, objectId=5d23112550cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d23112550cd, replyNumber=0, likeNumber=66, createdTime=2018-01-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d23112550cd, moduleTitle=美叫停CAR-T 韩启德院士带来新技术狂热下的冷思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d23112550cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781206, encodeId=99741e8120630, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！, objectType=article, longId=125530, objectId=ba02125530b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba02125530b8, replyNumber=0, likeNumber=109, createdTime=2018-08-08, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba02125530b8, moduleTitle=Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba02125530b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781195, encodeId=40441e81195bb, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CLIN CANCER RES：工程化分泌检查点抑制剂的CAR-T细胞免疫治疗疗效增强, objectType=article, longId=121281, objectId=d00612128112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00612128112, replyNumber=0, likeNumber=72, createdTime=2018-09-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00612128112, moduleTitle=CLIN CANCER RES：工程化分泌检查点抑制剂的CAR-T细胞免疫治疗疗效增强, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00612128112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781212, encodeId=a7c91e81212fe, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞治疗的现状及监管, objectType=article, longId=128273, objectId=82361282e39c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82361282e39c, replyNumber=0, likeNumber=98, createdTime=2018-12-09, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82361282e39c, moduleTitle=CAR-T细胞治疗的现状及监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82361282e39c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781202, encodeId=10b31e812027f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：CAR-T方法有望治愈多发性骨髓瘤, objectType=article, longId=123986, objectId=711112398669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711112398669, replyNumber=0, likeNumber=62, createdTime=2018-07-05, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711112398669, moduleTitle=Blood：CAR-T方法有望治愈多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711112398669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781179, encodeId=57f61e81179d2, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=重磅！全球CAR-T疗法获批，改写癌症治疗史！, objectType=article, longId=111687, objectId=4b1e11168eca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b1e11168eca, replyNumber=0, likeNumber=86, createdTime=2018-03-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b1e11168eca, moduleTitle=重磅！全球CAR-T疗法获批，改写癌症治疗史！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b1e11168eca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

全球CAR-T临床研究项目盘点：4年新增项目数量翻4.5倍

2018-02-14

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

科济生物启动全球CLDN18.2-CAR-T临床试验

2017-09-21

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nature：重磅！单个CAR-T细胞让癌症患者5年内保持无癌状态

2018-09-22

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

全球首条全自动、全封闭的CAR-T细胞CMC生产线首次亮相国内

2017-12-03

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

JAMA：CAR-T治疗：希望与挑战共存

2018-05-09

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Blood:CD19 CAR-T疗法引发脓毒症随意使用如同与虎谋皮？

2019-01-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

近50万美元的定价贵不贵？ CAR-T疗法或建立新“支付体系”

2017-10-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Leukemia：中科院广州生物院在CAR-T细胞免疫治疗研究上取得新进展

2018-06-05

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

欧盟，美国在加速审查诺华的CAR-T疗法Kymriah

2018-09-14

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

CLIN CANCER RES：靶向ICAM-1的CAR-T疗法治疗晚期甲状腺癌

2018-10-25

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

SCI TRANSL MED :大牛Carl June参与发表论文：CAR-T治疗实体瘤“人体试验”结果公布，有两大障碍需克服

2018-03-18

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

美国食药监局正式批准诺华公司CAR-T疗法，系全球首例

2018-03-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

糜坚青教授：CAR-T治疗新近进展及安全性管理策略

2018-08-24

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

继CAR-T之后，TCR技术或成为第3代免疫疗法明星

2017-10-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

美叫停CAR-T 韩启德院士带来新技术狂热下的冷思考

2018-01-16

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Leukemia：CD19靶向的CAR-T细胞有望安全有效的治愈难治性复发性急性B淋巴细胞白血病！

2018-08-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CLIN CANCER RES：工程化分泌检查点抑制剂的CAR-T细胞免疫治疗疗效增强

2018-09-11

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞治疗的现状及监管

2018-12-09

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Blood：CAR-T方法有望治愈多发性骨髓瘤

2018-07-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

重磅！全球CAR-T疗法获批，改写癌症治疗史！

2018-03-30

科室
- - 订阅+
  - 更多科室
工具
服务